EFC12703 Study - AVE0010 (Lixisenatide): Version 1.0

• Research type

  Research Study

• Full title

  A randomized, double-blind, placebo-controlled, 2-arm parallel-group, multicenter, 24-week study assessing the safety and efficacy of lixisenatide in older patients with type 2 diabetes inadequately controlled on their current diabetes treatment regimen.

• IRAS ID

  125698

• Contact name

  Iain McColl

• Contact email

  iaincmccoll@hotmail.com

• Sponsor organisation

  Sanofi

• Eudract number

  2012-003292-19

• Clinicaltrials.gov Identifier

  NCT01798706

• REC name

  West of Scotland REC 1

• REC reference

  13/WS/0097

• Date of REC Opinion

  4 Jun 2013

• REC opinion

  Further Information Favourable Opinion